Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Feb;39(2):467–475. doi: 10.1128/aac.39.2.467

Tobramycin uptake in Escherichia coli membrane vesicles.

I M Leviton 1, H S Fraimow 1, N Carrasco 1, T J Dougherty 1, M H Miller 1
PMCID: PMC162562  PMID: 7726517

Abstract

The uptake of tobramycin was measured in Escherichia coli membrane vesicles prepared in KMES [K(+)-2-(N-morpholino)ethanesulfonic acid] buffer at pH 6.6. Uptake occurred in vesicles energized with ascorbic acid and phenazine methosulfate, in which the electrical potential (delta psi) was -120 mV, but not in vesicles energized with D-lactate (delta psi = -95 mV). The addition of nigericin to vesicles energized with D-lactate did not induce tobramycin uptake despite an increase in delta psi to -110 mV. However, when delta psi was increased or decreased by the addition of nigericin or valinomycin, respectively, uptake in vesicles energized with ascorbic acid and phenazine methosulfate was stimulated or inhibited, respectively, confirming studies with whole cells showing that uptake of aminoglycosides is gated by delta psi rather than by proton motive force (delta microH+) or delta pH. N-ethylmaleimide prevented uptake, suggesting that the aminoglycoside transporter is a cytoplasmic membrane protein with accessible sulfhydryl groups. The observation that uptake is gated in vesicles as well as in whole cells suggested that diffusion occurs through a voltage-gated channel. In vesicles preloaded with tobramycin, no efflux occurred after the addition of the protonophore carbonyl cyanide m-chlorophenylhydrazone. In susceptible cells, aminoglycosides themselves decreased the magnitude of delta psi. We propose a mechanism of aminoglycoside-induced killing in which aminoglycosides themselves close the voltage-gated channel by decreasing the magnitude of delta psi. Channel closure causes aminoglycosides accumulated prior to the fall in delta psi to be trapped, which in turn causes irreversible uptake and subsequent bactericidal effects.

Full Text

The Full Text of this article is available as a PDF (257.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANAND N., DAVIS B. D., ARMITAGE A. K. Uptake of streptomycin by Escherichia coli. Nature. 1960 Jan 2;185:23–24. doi: 10.1038/185023a0. [DOI] [PubMed] [Google Scholar]
  2. ANAND N., DAVIS B. D. Damage by streptomycin to the cell membrane of Escherichia coli. Nature. 1960 Jan 2;185:22–23. doi: 10.1038/185022a0. [DOI] [PubMed] [Google Scholar]
  3. Ames G. F., Lecar H. ATP-dependent bacterial transporters and cystic fibrosis: analogy between channels and transporters. FASEB J. 1992 Jun;6(9):2660–2666. doi: 10.1096/fasebj.6.9.1377140. [DOI] [PubMed] [Google Scholar]
  4. Andry K., Bockrath R. C. Dihydrostreptomycin accumulation in E. coli. Nature. 1974 Oct 11;251(5475):534–536. doi: 10.1038/251534a0. [DOI] [PubMed] [Google Scholar]
  5. Bachmann B. J. Linkage map of Escherichia coli K-12, edition 8. Microbiol Rev. 1990 Jun;54(2):130–197. doi: 10.1128/mr.54.2.130-197.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bakker E. P. Aminoglycoside and aminocyclitol antibiotics: hygromycin B is an atypical bactericidal compound that exerts effects on cells of Escherichia coli characteristics for bacteriostatic aminocyclitols. J Gen Microbiol. 1992 Mar;138(3):563–569. doi: 10.1099/00221287-138-3-563. [DOI] [PubMed] [Google Scholar]
  7. Bryan L. E., Kowand S. K., Van Den Elzen H. M. Mechanism of aminoglycoside antibiotic resistance in anaerobic bacteria: Clostridium perfringens and Bacteroides fragilis. Antimicrob Agents Chemother. 1979 Jan;15(1):7–13. doi: 10.1128/aac.15.1.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bryan L. E., Kwan S. Mechanisms of aminoglycoside resistance of anaerobic bacteria and facultative bacteria grown anaerobically. J Antimicrob Chemother. 1981 Dec;8 (Suppl 500):1–8. doi: 10.1093/jac/8.suppl_d.1. [DOI] [PubMed] [Google Scholar]
  9. Bryan L. E., Kwan S. Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob Agents Chemother. 1983 Jun;23(6):835–845. doi: 10.1128/aac.23.6.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bryan L. E., Van Den Elzen H. M. Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria. Antimicrob Agents Chemother. 1977 Aug;12(2):163–177. doi: 10.1128/aac.12.2.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bryan L. E., Van den Elzen H. M. Streptomycin accumulation in susceptible and resistant strains of Escherichia coli and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1976 Jun;9(6):928–938. doi: 10.1128/aac.9.6.928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Busse H. J., Wöstmann C., Bakker E. P. The bactericidal action of streptomycin: membrane permeabilization caused by the insertion of mistranslated proteins into the cytoplasmic membrane of Escherichia coli and subsequent caging of the antibiotic inside the cells due to degradation of these proteins. J Gen Microbiol. 1992 Mar;138(3):551–561. doi: 10.1099/00221287-138-3-551. [DOI] [PubMed] [Google Scholar]
  13. Catterall W. A. Structure and function of voltage-sensitive ion channels. Science. 1988 Oct 7;242(4875):50–61. doi: 10.1126/science.2459775. [DOI] [PubMed] [Google Scholar]
  14. Cohn D. E., Kaczorowski G. J., Kaback H. R. Effect of the proton electrochemical gradient on maleimide inactivation of active transport in Escherichia coli membrane vesicles. Biochemistry. 1981 May 26;20(11):3308–3313. doi: 10.1021/bi00514a050. [DOI] [PubMed] [Google Scholar]
  15. Coleman W. G., Jr, Leive L. Two mutations which affect the barrier function of the Escherichia coli K-12 outer membrane. J Bacteriol. 1979 Sep;139(3):899–910. doi: 10.1128/jb.139.3.899-910.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Dalhoff A. Aminoglycoside accumulation by membrane vesicles of Escherichia coli and Streptococcus faecalis. Zentralbl Bakteriol Mikrobiol Hyg A. 1983 May;254(3):333–342. [PubMed] [Google Scholar]
  17. Damper P. D., Epstein W. Role of the membrane potential in bacterial resistance to aminoglycoside antibiotics. Antimicrob Agents Chemother. 1981 Dec;20(6):803–808. doi: 10.1128/aac.20.6.803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Davis B. D., Chen L. L., Tai P. C. Misread protein creates membrane channels: an essential step in the bactericidal action of aminoglycosides. Proc Natl Acad Sci U S A. 1986 Aug;83(16):6164–6168. doi: 10.1073/pnas.83.16.6164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Davis B. D. Mechanism of bactericidal action of aminoglycosides. Microbiol Rev. 1987 Sep;51(3):341–350. doi: 10.1128/mr.51.3.341-350.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Eisenberg E. S., Mandel L. J., Kaback H. R., Miller M. H. Quantitative association between electrical potential across the cytoplasmic membrane and early gentamicin uptake and killing in Staphylococcus aureus. J Bacteriol. 1984 Mar;157(3):863–867. doi: 10.1128/jb.157.3.863-867.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Emling F., Höltje J. V. Autostimulation of dihydrostreptomycin uptake in Bacillus subtilis. J Gen Microbiol. 1987 Dec;133(12):3495–3504. doi: 10.1099/00221287-133-12-3495. [DOI] [PubMed] [Google Scholar]
  22. Felle H., Porter J. S., Slayman C. L., Kaback H. R. Quantitative measurements of membrane potential in Escherichia coli. Biochemistry. 1980 Jul 22;19(15):3585–3590. doi: 10.1021/bi00556a026. [DOI] [PubMed] [Google Scholar]
  23. Fraimow H. S., Greenman J. B., Leviton I. M., Dougherty T. J., Miller M. H. Tobramycin uptake in Escherichia coli is driven by either electrical potential or ATP. J Bacteriol. 1991 May;173(9):2800–2808. doi: 10.1128/jb.173.9.2800-2808.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Gilman S., Saunders V. A. Accumulation of gentamicin by Staphylococcus aureus: the role of the transmembrane electrical potential. J Antimicrob Chemother. 1986 Jan;17(1):37–44. doi: 10.1093/jac/17.1.37. [DOI] [PubMed] [Google Scholar]
  25. Goss S. R., Spicer A. B., Nichols W. W. Bioenergetics of dihydrostreptomycin transport by Escherichia coli. FEBS Lett. 1988 Feb 15;228(2):245–248. doi: 10.1016/0014-5793(88)80008-5. [DOI] [PubMed] [Google Scholar]
  26. Hancock R. E. Aminoglycoside uptake and mode of action--with special reference to streptomycin and gentamicin. I. Antagonists and mutants. J Antimicrob Chemother. 1981 Oct;8(4):249–276. doi: 10.1093/jac/8.4.249. [DOI] [PubMed] [Google Scholar]
  27. Hoch D. H., Finkelstein A. Gating of large toxin channels by pH. Ann N Y Acad Sci. 1985;456:33–35. doi: 10.1111/j.1749-6632.1985.tb14841.x. [DOI] [PubMed] [Google Scholar]
  28. Kaback H. R. Transport across isolated bacterial cytoplasmic membranes. Biochim Biophys Acta. 1972 Aug 4;265(3):367–416. doi: 10.1016/0304-4157(72)90014-7. [DOI] [PubMed] [Google Scholar]
  29. Kashiwagi K., Kobayashi H., Igarashi K. Apparently unidirectional polyamine transport by proton motive force in polyamine-deficient Escherichia coli. J Bacteriol. 1986 Mar;165(3):972–977. doi: 10.1128/jb.165.3.972-977.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kashket E. R. Effects of aerobiosis and nitrogen source on the proton motive force in growing Escherichia coli and Klebsiella pneumoniae cells. J Bacteriol. 1981 Apr;146(1):377–384. doi: 10.1128/jb.146.1.377-384.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kinoshita N., Unemoto T., Kobayashi H. Proton motive force is not obligatory for growth of Escherichia coli. J Bacteriol. 1984 Dec;160(3):1074–1077. doi: 10.1128/jb.160.3.1074-1077.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  33. Mandel L. J., Eisenberg E. S., Simkin N. J., Miller M. H. Effect of N, N'-dicyclohexylcarbodiimide and nigericin on Staphylococcus aureus susceptibility to gentamicin. Antimicrob Agents Chemother. 1983 Sep;24(3):440–442. doi: 10.1128/aac.24.3.440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Marger M. D., Saier M. H., Jr A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport. Trends Biochem Sci. 1993 Jan;18(1):13–20. doi: 10.1016/0968-0004(93)90081-w. [DOI] [PubMed] [Google Scholar]
  35. Mates S. M., Eisenberg E. S., Mandel L. J., Patel L., Kaback H. R., Miller M. H. Membrane potential and gentamicin uptake in Staphylococcus aureus. Proc Natl Acad Sci U S A. 1982 Nov;79(21):6693–6697. doi: 10.1073/pnas.79.21.6693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Mates S. M., Patel L., Kaback H. R., Miller M. H. Membrane potential in anaerobically growing Staphylococcus aureus and its relationship to gentamicin uptake. Antimicrob Agents Chemother. 1983 Apr;23(4):526–530. doi: 10.1128/aac.23.4.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Matsushita K., Kaback H. R. D-lactate oxidation and generation of the proton electrochemical gradient in membrane vesicles from Escherichia coli GR19N and in proteoliposomes reconstituted with purified D-lactate dehydrogenase and cytochrome o oxidase. Biochemistry. 1986 May 6;25(9):2321–2327. doi: 10.1021/bi00357a004. [DOI] [PubMed] [Google Scholar]
  38. Miller M. H., Edberg S. C., Mandel L. J., Behar C. F., Steigbigel N. H. Gentamicin uptake in wild-type and aminoglycoside-resistant small-colony mutants of Staphylococcus aureus. Antimicrob Agents Chemother. 1980 Nov;18(5):722–729. doi: 10.1128/aac.18.5.722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Miller M. H., Wexler M. A., Steigbigel N. H. Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants. Antimicrob Agents Chemother. 1978 Sep;14(3):336–343. doi: 10.1128/aac.14.3.336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Muir M. E., van Heeswyck R. S., Wallace B. J. Effect of growth rate on streptomycin accumulation by Escherichia coli and Bacillus megaterium. J Gen Microbiol. 1984 Aug;130(8):2015–2022. doi: 10.1099/00221287-130-8-2015. [DOI] [PubMed] [Google Scholar]
  41. Nichols W. W. On the mechanism of translocation of dihydrostreptomycin across the bacterial cytoplasmic membrane. Biochim Biophys Acta. 1987;895(1):11–23. doi: 10.1016/s0304-4173(87)80014-9. [DOI] [PubMed] [Google Scholar]
  42. Nichols W. W., Young S. N. Respiration-dependent uptake of dihydrostreptomycin by Escherichia coli. Its irreversible nature and lack of evidence for a uniport process. Biochem J. 1985 Jun 1;228(2):505–512. doi: 10.1042/bj2280505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Nikaido H., Saier M. H., Jr Transport proteins in bacteria: common themes in their design. Science. 1992 Nov 6;258(5084):936–942. doi: 10.1126/science.1279804. [DOI] [PubMed] [Google Scholar]
  44. Nunoki K., Florio V., Catterall W. A. Activation of purified calcium channels by stoichiometric protein phosphorylation. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6816–6820. doi: 10.1073/pnas.86.17.6816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Ramos S., Schuldiner S., Kaback H. R. The electrochemical gradient of protons and its relationship to active transport in Escherichia coli membrane vesicles. Proc Natl Acad Sci U S A. 1976 Jun;73(6):1892–1896. doi: 10.1073/pnas.73.6.1892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Singer M., Baker T. A., Schnitzler G., Deischel S. M., Goel M., Dove W., Jaacks K. J., Grossman A. D., Erickson J. W., Gross C. A. A collection of strains containing genetically linked alternating antibiotic resistance elements for genetic mapping of Escherichia coli. Microbiol Rev. 1989 Mar;53(1):1–24. doi: 10.1128/mr.53.1.1-24.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Taber H. W., Mueller J. P., Miller P. F., Arrow A. S. Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev. 1987 Dec;51(4):439–457. doi: 10.1128/mr.51.4.439-457.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Thomson T. B., Crider B. P., Eagon R. G. The kinetics of dihydrostreptomycin uptake in Pseudomonas putida membrane vesicles: absence of inhibition by cations. J Antimicrob Chemother. 1985 Aug;16(2):157–163. doi: 10.1093/jac/16.2.157. [DOI] [PubMed] [Google Scholar]
  49. Wilson D. B. Cellular transport mechanisms. Annu Rev Biochem. 1978;47:933–965. doi: 10.1146/annurev.bi.47.070178.004441. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES